SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.66 Cr | ₹5.21 Cr | ₹4.97 Cr | - | - |
What is the latest Contingent Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1.66 Cr |
| Mar2025 | ₹5.21 Cr |
| Mar2024 | ₹4.97 Cr |
| Mar2020 | - |
| Mar2019 | - |
How is Contingent Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.66 Cr | -68.14 | |
| Mar2025 | ₹5.21 Cr | 4.87 | |
| Mar2024 | ₹4.97 Cr | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Contingent Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹800.9 Cr | -9% | -11.1% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -9% |
-11.1% |
29.3% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses